BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 28239937)

  • 1. Smoking does not influence disability accumulation in primary progressive multiple sclerosis.
    Javizian O; Metz LM; Deighton S; Koch MW
    Eur J Neurol; 2017 Apr; 24(4):624-630. PubMed ID: 28239937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of early versus late disability accumulation in primary progressive MS.
    Koch MW; Greenfield J; Javizian O; Deighton S; Wall W; Metz LM
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):615-21. PubMed ID: 25091366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural history of primary progressive multiple sclerosis.
    Koch M; Kingwell E; Rieckmann P; Tremlett H
    Neurology; 2009 Dec; 73(23):1996-2002. PubMed ID: 19996074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis.
    D'hooghe MB; Haentjens P; Nagels G; De Keyser J
    Eur J Neurol; 2012 Apr; 19(4):616-24. PubMed ID: 22117611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling the natural history of primary progressive multiple sclerosis.
    Harding KE; Wardle M; Moore P; Tomassini V; Pickersgill T; Ben-Shlomo Y; Robertson NP
    J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):13-9. PubMed ID: 24828900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis.
    Signori A; Izquierdo G; Lugaresi A; Hupperts R; Grand'Maison F; Sola P; Horakova D; Havrdova E; Prat A; Girard M; Duquette P; Boz C; Grammond P; Terzi M; Singhal B; Alroughani R; Petersen T; Ramo C; Oreja-Guevara C; Spitaleri D; Shaygannejad V; Butzkueven H; Kalincik T; Jokubaitis V; Slee M; Fernandez Bolaños R; Sanchez-Menoyo JL; Pucci E; Granella F; Lechner-Scott J; Iuliano G; Hughes S; Bergamaschi R; Taylor B; Verheul F; Edite Rio M; Amato MP; Sajedi SA; Majdinasab N; Van Pesch V; Sormani MP; Trojano M
    Mult Scler; 2018 Apr; 24(5):642-652. PubMed ID: 28382837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden.
    Beiki O; Frumento P; Bottai M; Manouchehrinia A; Hillert J
    JAMA Neurol; 2019 Jun; 76(6):665-671. PubMed ID: 30882868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study.
    Lorscheider J; Kuhle J; Izquierdo G; Lugaresi A; Havrdova E; Horakova D; Hupperts R; Duquette P; Girard M; Prat A; Grand'Maison F; Grammond P; Sola P; Ferraro D; Trojano M; Ramo-Tello C; Lechner-Scott J; Pucci E; Solaro C; Slee M; Van Pesch V; Sanchez Menoyo JL; van der Walt A; Butzkueven H; Kappos L; Kalincik T;
    Eur J Neurol; 2019 Feb; 26(2):363-370. PubMed ID: 30298572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis.
    D'hooghe MB; Haentjens P; Nagels G; Garmyn M; De Keyser J
    Mult Scler; 2012 Apr; 18(4):451-9. PubMed ID: 21952096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
    Pöhlau D; Przuntek H; Sailer M; Bethke F; Koehler J; König N; Heesen C; Späth P; Andresen I
    Mult Scler; 2007 Nov; 13(9):1107-17. PubMed ID: 17623736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression rates and sample size estimates for PPMS based on the CLIMB study population.
    Raghavan K; Healy BC; Carruthers RL; Chitnis T
    Mult Scler; 2015 Feb; 21(2):180-8. PubMed ID: 25070676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking, obesity, and disability worsening in PPMS: an analysis of the INFORMS original trial dataset.
    Koch MW; Mostert J; Repovic P; Bowen JD; Strijbis E; Uitdehaag B; Cutter G
    J Neurol; 2022 Mar; 269(3):1663-1669. PubMed ID: 34392376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T2 lesions and rate of progression of disability in multiple sclerosis.
    Mostert JP; Koch MW; Steen C; Heersema DJ; De Groot JC; De Keyser J
    Eur J Neurol; 2010 Dec; 17(12):1471-5. PubMed ID: 20500805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette smoking and progression in multiple sclerosis.
    Koch M; van Harten A; Uyttenboogaart M; De Keyser J
    Neurology; 2007 Oct; 69(15):1515-20. PubMed ID: 17923613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry.
    Braune S; Bluemich S; Bruns C; Dirks P; Hoffmann J; Heer Y; Rouzic EM; Bergmann A;
    BMC Neurol; 2023 Jul; 23(1):258. PubMed ID: 37407914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking and disease progression in multiple sclerosis.
    Healy BC; Ali EN; Guttmann CR; Chitnis T; Glanz BI; Buckle G; Houtchens M; Stazzone L; Moodie J; Berger AM; Duan Y; Bakshi R; Khoury S; Weiner H; Ascherio A
    Arch Neurol; 2009 Jul; 66(7):858-64. PubMed ID: 19597087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.
    Shirani A; Zhao Y; Karim ME; Evans C; Kingwell E; van der Kop ML; Oger J; Gustafson P; Petkau J; Tremlett H
    JAMA; 2012 Jul; 308(3):247-56. PubMed ID: 22797642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history of primary progressive MS in British Columbia, Canada.
    Tremlett H; Paty D; Devonshire V
    Neurology; 2005 Dec; 65(12):1919-23. PubMed ID: 16380613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
    Galego O; Gouveia A; Batista S; Moura C; Machado E
    Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of different types of smoking on recovery from attack in hospitalized multiple sclerosis patients.
    Hosseini M; Haghighatzadeh M; Hassanpour R; Asadollahzadeh E; Rezaeimanesh N; Eskandarieh S; Navardi S; Ghadiri F; Moghadasi AN; Sahraian MA
    Clin Neurol Neurosurg; 2023 Sep; 232():107846. PubMed ID: 37467576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.